News & Events

Australia’s world-class medical research has transformed cancer care, but patients may not see the benefits of new genetic testing without new funding models.

Using genomic tools for detection and monitoring of circulating tumour DNA (ctDNA) in patient blood samples to enable cancer detection, surveillance and recurrence screening.

Genomics platform to understand the varied types of disease progression of patients with COVID-19, which will help to identify what treatment is best suited to individual patients.

Cancer treatment is largely based on where it originates in the body, but when a primary site can’t be found, genomics is helping guide diagnosis and treatment for cancers of unknown origin.

With the COVID-19 pandemic highlighting the importance of testing, and our capacity to undertake it at large scale, can we use these testing strategies for earlier diagnosis of cancer?

The University of Melbourne, together with international genomics company, Illumina, have welcomed the Victorian Government’s support to establish a $60 million world-leading genomics hub in Victoria.